Prostate Completed Phase 2 Trials for Tadalafil (DB00820)

IndicationStatusPhase
DBCOND0029764 (Prostate)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00547625Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract ProblemsTreatment